BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37839635)

  • 1. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
    Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
    Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma.
    Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL
    BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
    Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
    Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
    Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
    J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
    Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
    World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling.
    Cao N; Mu L; Yang W; Liu L; Liang L; Zhang H
    Biomed Pharmacother; 2018 Oct; 106():483-490. PubMed ID: 29990836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
    Jiang J; Xu B; Zheng Y; Guo X; Chen F
    Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
    Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
    Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.
    Zhang T; Ma Z; Liu L; Sun J; Tang H; Zhang B; Zou Y; Li H
    Cell Death Dis; 2018 Jun; 9(6):675. PubMed ID: 29867138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
    Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
    J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
    Liu Y; Ma J; Lu S; He P; Dong W
    Chin Med J (Engl); 2023 Sep; 136(18):2229-2242. PubMed ID: 37439386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantothenate Kinase 1 Inhibits the Progression of Hepatocellular Carcinoma by Negatively Regulating Wnt/β-catenin Signaling.
    Zi Y; Gao J; Wang C; Guan Y; Li L; Ren X; Zhu L; Mu Y; Chen SH; Zeng Z; Cao Z; Rong Z; Chen P; Zhang X; Chen T; Xin H; Li X; Li Z; Sun L; Deng Y; Li N; Nie Y
    Int J Biol Sci; 2022; 18(4):1539-1554. PubMed ID: 35280671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
    Xu H; Li B
    Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
    Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
    J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling.
    Qiao W; Wang H; Zhang X; Luo K
    Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.